Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Merck and NSTI Nanotech Now Accepting Abstracts for Consideration for the Merck Corporate Symposium on Targeted Delivery of siRNA

Abstract:
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA. The Symposium will provide an important platform for Merck to engage leading researchers in the nano tech community and create a discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.

Merck and NSTI Nanotech Now Accepting Abstracts for Consideration for the Merck Corporate Symposium on Targeted Delivery of siRNA

CAMBRIDGE, MA | Posted on October 24th, 2007

Merck places a strong emphasis on innovation in all areas of drug research, development and commercialization. "Merck is pleased to partner with the NSTI in bringing this Symposium to Greater Boston, a leading region for the life sciences industry and advanced patient care," said Dr. Reid Leonard, Merck's Executive Director of Licensing and External Research. "Nanotech 2008 reflects our commitment to innovation and provides an ideal forum for the presentation of siRNA enabling technologies - an area where Merck has assumed a leadership role."

NSTI Nanotech 2008 will be held June 1-5 at the Hynes Convention Center in Boston, MA. Entering its 11th year, Nanotech 2008 is the world's largest and most comprehensive technical and business event in nanotechnology. "Merck's Corporate Symposium will be one of the highlights of next year's conference," noted Dr. Bart Romanowicz, Executive Director of the Nano Science and Technology Institute. "We are delighted that Merck, one of the largest pharmaceutical companies in the world, has partnered with Nanotech 2008 to help address their company's advanced research needs."

To participate in the Merck Corporate Symposium, please submit your abstract through the Nanotech On-Line Abstract Submission form by December 6th, 2007: http://www.nsti.org/Nanotech2008/symposia/Merck.html .

####

About Nano Science and Technology Institute (NSTI)
The Nano Science and Technology Institute (NSTI; http://www.nsti.org ) is chartered with the advancement and integration of nano and other advanced technologies through education, collaboration and research services. Nanotech 2008 is expected to attract more than 4,000 industrial, academic, business and governmental attendees from around the world.

About Merck:

Merck & Co., Inc. ( http://www.merck.com ) is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

For more information, please click here

Contacts:
The Nano Science and Technology Institute
Jennifer Rocha, 508-357-2925

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Events/Classes

NNCO Announces an Interactive Webinar: Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy July 23rd, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

Iran to Hold 3rd Int'l Forum on Nanotechnology Economy July 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE